A significant breakthrough in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This crucial cancer inhibitor protein is frequently inactivated in several types of cancer, resulting https://bookmarkize.com/story22011568/mini-antibodies-restore-the-p53-protein-new-new-hope-for-malignant-therapy